Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

Clinical trial NCT05385991 · COMPLETED

Trial details

NCT number: NCT05385991
Sponsor: ACM Biolabs
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2022-07-01
Primary completion: 2023-06-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.